These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.
3,609 critical product recalls that require immediate attention. These products have been identified as posing serious safety hazards.
B. Braun Medical recalled 105,550 BBraun Medical 21G X4.4CM Winged INF devices worldwide, including Texas and Costa Rica. A dull or blunt needle tip may be difficult to advance or break. Healthcare providers and patients should stop using the device and follow the manufacturer's recall instructions.
B. Braun Medical is recalling 21,000 21GA Winged Infusion Sets (Single Pack) distributed worldwide, including Texas and Costa Rica, catalog 7A3842. The needle tip can be dull or blunt, may be difficult to advance, or break. Clinicians and patients should stop using the device and await manufacturer instructions.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.
B. Braun Medical recalls 51,300 units of its 21GA Winged Infusion Set, model 7M2802, distributed worldwide including Texas and Costa Rica. The device’s needle tip can be dull or break, making advancement difficult. Stop using the device immediately and contact the manufacturer or your healthcare provider for instructions.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.
Heart valves were released and distributed before all required testing was complete, so it cannot be confirmed that they meet all release specifications.
Costco recalled 8,073 packages of Kirkland Signature Mini Beignets on January 31, 2026. The products contain undeclared hazelnut, posing a serious risk to those with allergies. The beignets were distributed in multiple states including California and Texas.
Medline Industries recalls 2,894 Aqua-Seal Chest Drainage Units from Cardinal Health after updating IFUs to specify adult patients 18 years and older. The devices were distributed worldwide, including California, Chile and Panama. The update clarifies intended patient population and requires action from healthcare providers to stop use until further notice.
Reser's Fine Foods recalled 298 tubs of Tuna Salad on January 30, 2026 due to undeclared fish allergens. The product was mislabeled with a Chicken Salad lid, posing a risk to consumers with fish allergies. The recall affects distribution in Arizona, California, Nevada, Utah, and Washington.
J2C Hawaii recalled Tiki Bar Candy Dark Chocolatey Peanut Butter & Pretzel on January 30, 2026. The recall affects approximately 300 units distributed in Hawaii. The product mislabels peanuts, posing a risk to consumers with peanut allergies.
Beckman Coulter Mishima K.K. recalled 142 DxC 700 AU clinical chemistry analyzers nationwide in the United States. The recall cites a software issue that can delay test results. Labs should stop using the device and follow manufacturer instructions for service and remediation.
Covidien recalled 78 HealthCast Vital Sync Remote Patient Monitoring Systems sold worldwide, including in the United States. Alarms from the bedside monitor may not alarm or transmit to the remote system. Healthcare providers and patients should stop using the device immediately and await recall instructions.
Beckman Coulter Mishima K.K. recalled 47 AU5800 chemistry analyzers sold nationwide in the United States after a software delay can cause calibration and reagent databases to fail to open. The issue occurs when a calibration monitor using Microsoft SQL Server 2022 Express remains open for more than 15 minutes, potentially halting analysis. Healthcare facilities should stop using the devices and (a
Medtronic MiniMed recalled 26,851 MiniMed 780G insulin pumps sold worldwide, including the United States and Israel. Three software defects tied to updates 6.60, 6.61, and 6.62 could misdose insulin. Stop using the affected pumps and follow the recall letter for instructions.
Tandem Diabetes Care recalled 1,380 insulin infusion pumps distributed internationally in the Czech Republic and Slovakia after translation errors in the Czech user guide could cause unintended insulin delivery. The most significant error told users to verify the infusion set is connected to the body when it should be confirming it is not connected. Following this instruction could result in a hyp
Paradise Renal Denervation Catheter was recalled after a single unit distributed nationwide in nine states was deemed nonconforming and not for human use. The device is an ultrasound renal denervation catheter. Healthcare providers should stop using it and contact ReCor Medical for instructions.
ReCor Medical Inc. has issued an active recall for 24 Paradise ultrasound renal denervation catheters distributed nationwide in nine states. The devices were nonconforming and were supposed to be scrapped and not for human use. Healthcare providers and patients should stop using the devices immediately and await manufacturer recall instructions.
Viofairy recalled its Hair Growth Serum on January 29, 2026, due to serious poisoning risks. The packaging lacks required child-resistant features, endangering young children. Consumers must stop using the product immediately and secure it out of reach.
Teva Pharmaceuticals is recalling 18,780 bottles of Metoprolol Succinate Extended-Release Tablets, 25 mg, distributed nationwide. The recall is due to failed dissolution specifications that could affect dosing. Patients should stop using affected bottles and contact Teva or their healthcare provider for guidance.
Teva Pharmaceuticals recalled 19,056 bottles of Metoprolol Succinate Extended-Release Tablets, 200 mg, sold nationwide. The recall cites failed dissolution specifications, which could affect how the drug releases in the body. Patients should stop using the product and contact Teva or their healthcare provider for guidance.